Alligator Bioscience AB (publ) (STO:ATORX)

Alligator Bioscience AB Revenue

Alligator Bioscience AB had revenue of 98.00K SEK in the quarter ending March 31, 2026, a decrease of -98.11%. This brings the company's revenue in the last twelve months to 1.34M, down -97.67% year-over-year. In the year 2025, Alligator Bioscience AB had annual revenue of 6.42M, down -89.25%.

• Revenue (ttm): 1.34M
• Revenue Growth: -97.67%
• P/S Ratio: 60.88
• Revenue / Employee: 47.27K
• Employees: 11
• Market Cap: 31.66M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.42M	-53.29M	-89.25%
Dec 31, 2024	59.71M	-2.19M	-3.54%
Dec 31, 2023	61.90M	24.77M	66.69%
Dec 31, 2022	37.14M	22.01M	145.50%
Dec 31, 2021	15.13M	8.46M	126.88%
Dec 31, 2020	6.67M	1.27M	23.55%
Dec 31, 2019	5.40M	-23.12M	-81.08%
Dec 31, 2018	28.51M	-29.26M	-50.64%
Dec 31, 2017	57.77M	-1.58M	-2.66%
Dec 31, 2016	59.35M	-234.27M	-79.79%
Dec 31, 2015	293.62M	292.45M	24,974.21%
Dec 31, 2014	1.17M	-	-

Data Source: Fiscal.ai Last updated: May 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 22, 2026

Data Sources Report a data error